Shares of GSK PLC GSK inched down 0.51% to £13.57 Friday, on what proved to be an all-around poor trading session for the ...

Ken Hall looks at three important considerations for investors looking to build a sizeable passive income for a better financial future.

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

Bonus Sep 11, 2018 Sep 13, 2018 Jul 24, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jan 02, 1995 Jan 24, 1995 Sep 28, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 21, ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

If a threshold of 10% risk of COPD was used to make spirometry referrals, the addition of the polygenic risk score correctly ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

Barbara Salami is the VP of Digital for Commercial at Moderna where she is leads digital transformation for Moderna’s new ...

In an exclusive interview with SheKnows, Brooke Shields talked about aging, health, and how she talks about all of this with ...